Christopher Aston to Alleles
This is a "connection" page, showing publications Christopher Aston has written about Alleles.
Connection Strength
0.400
-
Allele C-specific methylation of the 5-HT2A receptor gene: evidence for correlation with its expression and expression of DNA methylase DNMT1. J Neurosci Res. 2006 Feb 15; 83(3):362-73.
Score: 0.061
-
Log-linear model analysis of allelic associations. Genet Epidemiol. 1986; 3(3):187-94.
Score: 0.061
-
APOC3 genetic variation, serum triglycerides, and risk of coronary artery disease in Asian Indians, Europeans, and other ethnic groups. Lipids Health Dis. 2021 Sep 21; 20(1):113.
Score: 0.045
-
A simple allele sharing statistic for multiple locus systems. Genet Epidemiol. 1999; 17 Suppl 1:S497-501.
Score: 0.037
-
Genetic effect of apolipoprotein(a) and apolipoprotein E polymorphisms on plasma quantitative risk factors for coronary heart disease in American black women. Atherosclerosis. 1995 Sep; 117(1):73-81.
Score: 0.030
-
Association of APOE polymorphisms with diabetes and cardiometabolic risk factors and the role of APOE genotypes in response to anti-diabetic therapy: results from the AIDHS/SDS on a South Asian population. J Diabetes Complications. 2015 Nov-Dec; 29(8):1191-7.
Score: 0.029
-
Expression and distribution of the class III ubiquitin-conjugating enzymes in the retina. Mol Vis. 2010 Nov 18; 16:2425-37.
Score: 0.021
-
Single nucleotide polymorphism in prohibitin 3' untranslated region and breast-cancer susceptibility. Lancet. 2001 May 19; 357(9268):1588-9.
Score: 0.011
-
DNA sequence variation in human apolipoprotein C4 gene and its effect on plasma lipid profile. Atherosclerosis. 2000 Sep; 152(1):193-201.
Score: 0.010
-
Racial differences in the distribution of a low density lipoprotein receptor-related protein (LRP) polymorphism and its association with serum lipoprotein, lipid and apolipoprotein levels. Atherosclerosis. 1998 Mar; 137(1):187-95.
Score: 0.009
-
Association between ACT polymorphism and Alzheimer's disease. Neurology. 1998 Feb; 50(2):574-6.
Score: 0.009
-
Fine mapping of an imprinted gene for familial nonchromaffin paragangliomas, on chromosome 11q23. Am J Hum Genet. 1997 Jan; 60(1):121-32.
Score: 0.008
-
Polygenic determinants of Alzheimer's disease: modulation of the risk by alpha-1-antichymotrypsin. Ann N Y Acad Sci. 1996 Dec 16; 802:27-34.
Score: 0.008
-
Quantitative effects of the apolipoprotein E polymorphism in a biracial sample of 9-10-year-old girls. Atherosclerosis. 1996 Sep 27; 126(1):35-42.
Score: 0.008
-
Population distributions of APOE, APOH, and APOA4 polymorphisms and their relationships with quantitative plasma lipid levels among the Evenki herders of Siberia. Hum Biol. 1996 Apr; 68(2):231-43.
Score: 0.008
-
The relationship of APOE polymorphism and cholesterol levels in normoglycemic and diabetic subjects in a biethnic population from the San Luis Valley, Colorado. Atherosclerosis. 1995 Jan 20; 112(2):145-59.
Score: 0.007
-
Genetic characterization of American and Western Samoans. Hum Biol. 1994 Oct; 66(5):805-22.
Score: 0.007
-
Conservation of human chromosome 13 polymorphic microsatellite (CA)n repeats in chimpanzees. Genomics. 1994 Jul 01; 22(1):226-30.
Score: 0.007
-
Role of common genetic polymorphisms in the LDL receptor gene in affecting plasma cholesterol levels in the general population. Arterioscler Thromb. 1994 May; 14(5):663-70.
Score: 0.007
-
Impact of apolipoprotein E polymorphism in determining interindividual variation in total cholesterol and low density lipoprotein cholesterol in Hispanics and non-Hispanic whites. Atherosclerosis. 1993 Jan 25; 98(2):201-11.
Score: 0.006
-
Molecular basis of a unique African variant (A-IV 5) of human apolipoprotein A-IV and its significance in lipid metabolism. Genet Epidemiol. 1992; 9(6):379-88.
Score: 0.006
-
Apolipoprotein A-IV polymorphism, and its role in determining variation in lipoprotein-lipid, glucose and insulin levels in normal and non-insulin-dependent diabetic individuals. Atherosclerosis. 1991 Nov; 91(1-2):25-34.
Score: 0.006